Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HYPERTENSION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | HYPERTENSION |
| Key Genes/Proteins | AMPK, AMYLOID, BACE1, CYTOKINES, EGFR |
| Related Diseases | ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, BREAST CANCER, cerebral small vessel disease, CIRRHOSIS |
graph TD
HYPERTENSION["HYPERTENSION"]
HYPERTENSION -->|"contributes to"| Oxidative_Stress["Oxidative Stress"]
HYPERTENSION -->|"target for"| Pi3K["Pi3K"]
HYPERTENSION -->|"activates"| Autophagy["Autophagy"]
HYPERTENSION -->|"activates"| Apoptosis["Apoptosis"]
HYPERTENSION -->|"target for"| Blood_Brain_Barrier["Blood-Brain Barrier"]
HYPERTENSION -->|"target for"| Epigenetic["Epigenetic"]
HYPERTENSION -->|"target for"| Amyloid["Amyloid"]
superoxide_anion["superoxide anion"] -->|"causes"| HYPERTENSION
PIEZO1["PIEZO1"] -->|"activates"| HYPERTENSION
KCNK2["KCNK2"] -->|"activates"| HYPERTENSION
TRPC1["TRPC1"] -->|"activates"| HYPERTENSION
TRPV4["TRPV4"] -->|"activates"| HYPERTENSION
FSP1["FSP1"] -->|"activates"| HYPERTENSION
TRPA1["TRPA1"] -->|"regulates"| HYPERTENSION
G3BP1["G3BP1"] -->|"activates"| HYPERTENSION| Target | Relation | Type | Str |
|---|---|---|---|
| Heart Failure | associated_with | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Metabolic Syndrome | associated_with | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Cardiovascular | associated_with | disease | 1.00 |
| Obesity | associated_with | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Insulin Resistance | associated_with | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 0.95 |
| Cardiac | associated_with | disease | 0.95 |
| Heart Failure | activates | disease | 0.95 |
| Inflammation | associated_with | disease | 0.95 |
| Vascular Remodelling | associated_with | process | 0.95 |
| Cardiovascular Disease | risk_factor_for | disease | 0.90 |
| cerebral small vessel disease | causes | disease | 0.90 |
| Arteriolosclerosis | risk_factor_for | disease | 0.90 |
| Arteriolosclerosis | causes | disease | 0.88 |
| Cardiac | activates | disease | 0.85 |
| Stroke | associated_with | disease | 0.85 |
| Gene Expression | modulates | process | 0.85 |
| Atherosclerosis | associated_with | disease | 0.85 |
| Aging | associated_with | disease | 0.85 |
| Alzheimer's Disease | risk_factor_for | disease | 0.80 |
| Cerebral Hypoperfusion | causes | mechanism | 0.80 |
| Oxidative Stress | therapeutic_target | pathway | 0.80 |
| Oxidative Stress | activates | pathway | 0.80 |
| Autophagy | activates | pathway | 0.80 |
| Apoptosis | associated_with | pathway | 0.80 |
| Neurofilament Light | associated_with | biomarker | 0.79 |
| Glial Fibrillary Acidic Protein | associated_with | biomarker | 0.79 |
| White Matter Hyperintensity | causes | phenotype | 0.78 |
| neurodegeneration | contributes_to | process | 0.75 |
| Aging | activates | disease | 0.75 |
| Coronary Artery Disease | associated_with | disease | 0.75 |
| Heart Failure | therapeutic_target | disease | 0.75 |
| Plasma Biomarker Changes | associated_with | process | 0.75 |
| Als | inhibits | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| Als | treats | disease | 0.75 |
| Alzheimer | therapeutic_target | disease | 0.75 |
| Cholesterol | activates | pathway | 0.70 |
| Toll-Like Receptor | therapeutic_target | pathway | 0.70 |
| Mapk | implicated_in | pathway | 0.70 |
| Cholesterol | associated_with | pathway | 0.70 |
| Cerebral Perfusion | inhibits | process | 0.70 |
| Oxidative Stress | causes | pathway | 0.70 |
| Mapk | activates | pathway | 0.70 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Cardiovascular | associated_with | disease | 1.00 |
| Diabetes | associated_with | disease | 1.00 |
| INSULIN RESISTANCE | associated_with | gene | 1.00 |
| STROKE | associated_with | gene | 1.00 |
| DIABETES MELLITUS | associated_with | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 0.95 |
| INFLAMMATION | associated_with | gene | 0.95 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.95 |
| DIABETES MELLITUS | causes | gene | 0.95 |
| PAH | associated_with | gene | 0.95 |
| microglia | implicated_in | cell_type | 0.90 |
| Endothelial Cell Senescence | associated_with | process | 0.90 |
| Short-Chain Fatty Acids | risk_factor_for | compound | 0.85 |
| ALZHEIMER | associated_with | gene | 0.85 |
| INFLAMMATION | causes | gene | 0.85 |
| CYTOKINES | activates | gene | 0.85 |
| INFLAMMATION | therapeutic_target | gene | 0.85 |
| NEUROINFLAMMATION | therapeutic_target | gene | 0.85 |
| GENES | associated_with | gene | 0.85 |
| NEURODEGENERATION | inhibits | gene | 0.85 |
| APOPTOSIS | implicated_in | gene | 0.85 |
| Microglia | involved_in | cell_type | 0.85 |
| CANCER | associated_with | gene | 0.85 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.85 |
| Microglia Activation | associated_with | process | 0.85 |
| ALZHEIMER | therapeutic_target | gene | 0.85 |
| NEURODEGENERATION | associated_with | gene | 0.85 |
| AGING | associated_with | gene | 0.85 |
| NEURODEGENERATION | activates | gene | 0.85 |
| Alcohol Consumption | risk_factor_for | phenotype | 0.85 |
| OXIDATIVE STRESS | regulates | gene | 0.85 |
| Oxidative Stress | contributes_to | process | 0.85 |
| AUTOPHAGY | activates | gene | 0.85 |
| BDNF | associated_with | gene | 0.85 |
| AGING | activates | gene | 0.85 |
| AMPK | activates | gene | 0.85 |
| Neuroinflammation | contributes_to | process | 0.85 |
| CYTOKINES | causes | gene | 0.85 |
| Diabetes | activates | disease | 0.85 |
| Microglia | regulates | cell_type | 0.80 |
| Ion Channel Dysfunction | associated_with | process | 0.80 |
| Ion Channel Dysfunction | associated_with | mechanism | 0.80 |
| HCRT | associated_with | gene | 0.80 |
| SCFA | associated_with | chemical | 0.80 |
| 20-HETE | causes | entity | 0.80 |
| superoxide anion | causes | phenotype | 0.80 |
| Autonomic Nervous System Dysfunction | contributes_to | phenotype | 0.78 |
| OPTN | activates | gene | 0.75 |
| DEMENTIA | activates | gene | 0.75 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning HYPERTENSION in their description or question text
No additional research found